Sign in

NCT06923215Not yet recruiting

Glucose Disposal Rate as a Metric for Detection of Metabolic Associated Fatty Liver

The Role of Estimated Glucose Disposal Rate as a Metric for Detection of Metabolic Associated Fatty Liver Disease and Its Severity in Patients With Metabolic Syndrome.

Source: ClinicalTrials.gov · Last updated 11 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

A 12-month prospective observational cohort study assessing eGDR's utility in diagnosing MAFLD (via FibroScan® CAP ≥248 dB/m) and correlating it with steatosis/fibrosis severity. Secondary aims compare eGDR to FLI/FIB-4 scores and identify optimal diagnostic cut-offs

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
30 (estimated)
First submitted
4 Apr 2025
Start date
30 Jul 2025
Primary completion date
30 Nov 2026
Lead sponsor
Assiut University
NCT number
NCT06923215

What you commit to

  • Study type: Observational
  • Planned participants: 30
  • From 30 Jul 2025 to the primary completion date, 30 Nov 2026
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Other liver diseases (viral/autoimmune hepatitis).
    • Alcohol intake \>20 g/day (men) or \>10 g/day (women).
    • Pregnancy, malignancy, advanced cirrhosis.
    • Medications affecting metabolism (e.g., steroids)

Who the study is looking for

  • Age 18-65 years.
  • Suspected/confirmed MS per IDF criteria:
  • Central obesity (waist circumference ≥94 cm \[men\]/≥80 cm \[women\]) plus ≥2 of: Triglycerides ≥150 mg/dL.
    • HDL \<40 mg/dL (men)/\<50 mg/dL (women). Blood pressure ≥130/85 mmHg or antihypertensive treatment. Fasting glucose ≥100 mg/dL or diabetes diagnosis.

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.